
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
LATEST POSTS
- 1
Artemis II live updates: NASA's moon mission breaks Apollo record for farthest distance humans have traveled from Earth - 2
Trump awarded 1st FIFA Peace Prize by Gianni Infantino at 2026 World Cup draw - 3
Ads promising cosmetic surgery patients a ‘dream body’ with minimal risk get little scrutiny - 4
2024 Moving Styles for Kitchen Redesigns - 5
Two Indonesian UN peacekeepers killed in explosion in Lebanon
Dave Coulier reveals he has tongue cancer, his 2nd diagnosis in a year, after beating non-Hodgkin lymphoma
Grasping the Qualifications Among Separation and Dissolution
Tech Patterns: Contraptions That Will Shape What's in store
Horror and fear in West Bank as Israel approves hanging Palestinians convicted of murdering Israelis
Aluminum salts emerge as likely target as health officials scrutinize childhood vaccines
Vietnam rethinks its flood strategy as climate change drives storms and devastation
Iran fires one of largest barrages in weeks ahead of Passover
Exploring the Difficulties of Beginning a Family: Individual Experiences
Ageless Tastefulness: An Outline of Valuable Gemstones and Adornments












